References
- European Multicentre Trial Group. Cyclosporin in cadaveric renal transplantation: one year follow-up of a multicenter trial. Lancet 1980; 2: 986–989
- Canadian Multicentre Transplant Study Group. A randomized clinical trial of cyclosporin in cadaveric renal transplantation. N Engl J Med 1986; 314: 1219–1225
- Sutherland D ER, Strand M, Fryd D A, Ferguson R M, Simmons R L, Ascher N L, Najarian J S. Comparison of azathioprine anti-lymphocyte globuline versus cyclosporine in renal transplantation. Am J Kidney Dis 1984; 60: 456–461
- Peterson P K, Rynasiewicz J J, Simmons R L, Ferguson R M. Decreased incidence of overt cytomegalovirus disease in renal allograft recipients receiving cyclosporin-A. Transplant Proc 1983; 15: 457–459
- Henny F C, Kootte A MM, van Bockel J H, Baldwin W M, Hermans J, Bos B, van Es L A, Paul L C. A prospective randomised comparative study on the influence of cyclosporin A and azathioprine on renal allograft survival and function. Nephrol Dial Transplant 1986; 1: 44–49
- Cuvelier R, Pirson Y, Alexandre G PJ. Late urinary tract infection after transplantation: prevalence, predisposition and morbidity. Nephron 1985; 40: 76–78
- Masur H, Cheigh J S, Studenbord W T. Infections following renal transplantation; a changing pattern. Rev Infect Dis 1982; 4: 1208–1219
- Peterson P K, Ferguson R, Balfour H H, Naiewicz J R, Simmons R L, Fryd D S. Infectious diseases in hospitalized renal transplant recipients: a prospective study of a complex and evolving problem. Medicine (Baltimore) 1982; 61: 360–372
- Myers B D, Ross J, Newton L, Leutscher J, Perltroth M. Cyclosporine-associated chronic nephropathy. N Engl J Med 1984; 311: 699–705
- Morris P J, French M E, Dunnill M S, Hunnisett A GW, Thing A, Thompson J F, Wood R FM. A controlled trial of cyclosporine in renal transplantation with conversion to azathioprine and prednisolone after three months. Transplantation 1983; 36: 273–277
- Hoitsma A J, Wetzels J F, van Lier H JJ, Berden J HM, Koene R AP. Cyclosporin treatment with conversion after three months versus conventional immunosuppression in renal allograft recipients. Lancet 1987; 1: 584–586
- Bia M J, Andiman W, Gaudi K, Kliger A, Siegel N, Smith D, Five W. Effect of treatment with cyclosporin versus azathioprine on incidence and severity of cytomegalovirus infections posttransplantation. Transplantation 1985; 40: 610–614
- Snydman D R, Werner B G, Heinze-Lacey G. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal transplant recipients. N Engl J Med 1987; 317: 1049–1054